You are here

Kansere Bağlı Ağrı ve Tedavisi

Cancer-Related Pain and Treatment

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Pain due to cancer, more than half of cancer patients, in any period of the disease affecting is one of the most important issues that disrupt the quality of life of patients. Mitigation and prevention of recurrence pain in cancer patients as soon as possible should be targeted. For this purpose, in general, methods of treatment are accounted for as non-invasive and invasive. The World Health Organization (WHO) according to the severity of non-opioid pain, weak opioid therapy and proposes the use of strong opioids a 3-digit consecutive steps. However, health professionals, patients and their relatives rates up to 80% due to prejudice due to pain pallia-tion is failed. In this review, evaluation and treatment of cancer-related pain aimed to review the options.
Abstract (Original Language): 
Kansere bağlı ağrı; kanser hastalarının yarıdan fazlasını, hastalığın herhangi bir döneminde etkileyerek, hastaların yaşam kalitelerini bozan en önemli sorunlardan biridir. Kan-ser hastalarında ağrının en kısa sürede hafifletilmesi ve tekrarının önlenmesi amaçlanmalıdır. Bu amaçla yapılan tedavi yöntemleri genel olarak noninvaziv ve invaziv olarak ayrılmaktadır. Dünya Sağlık Örgütü (WHO) ağrının şiddetine göre non-opioid, zayıf opioid ve güçlü opioidlerin kullanıldığı 3 basamaklı ardışık merdiven tedavisi uygulanmasını öner-mektedir. Fakat sağlık çalışanları, hasta ve hasta yakınlarına bağlı önyargılar nedeniyle %80’lere varan oranlarda ağrı palyasyonunda yetersiz olunmaktadır. Bu derlemede kanse-re bağlı ağrının özellikleri, değerlendirilmesi, tedavisi ve bu konudaki seçeneklerin gözden geçirilmesi amaçlandı.
256
260

REFERENCES

References: 

1. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain 1985; 22(1): 1-31.
2. Sarıhan E,Kadıoğlu E,Artıran İğde F. Kanser Ağrısı, Tedavi Prensipleri ve Dünya Sağlık Örgütü Ağrı Basamak Tedavisi. Nobel Med 2012;8(1): 5-15.
3. Eti Z. Kansede ağrı tedavisi. Üroonkoloji Bülteni 2005;2: 16-20.
4-Paice JA, Ferrell B.The management of cancer pain. CA Cancer J Clin 2011;61(3):157-82.
5. Ripamonti CI, Bandieri E, Roila F; ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines.Ann Oncol 2011; 22 (6): 69-77.
6-Fleishman SB.Treatment of symptom clusters: pain, depression, and fatigue. J Natl Cancer Inst Monog 2004;(32):119-23.
7-Mitra R, Jones S. Adjuvant analgesics in cancer pain: a review. Am J Hosp Palliat Car 2012;29(1):70-9.
8-Coyle N, Layman-Goldstein M.Pharmacologic manage-ment of adult cancer pain. Oncology (Williston Park) 2007;21(2): 10-22.
9-McNicol E, Strassels SA, Goudas L, Lau J, Carr DB.NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 2005 25;(1):CD005180.
10- Davis MP, Lasheen W, Gamier P.Practical guide to opioids and their complications in managing cancer pain. What oncologists need to know. Oncology (Williston Park) 2007;21(10):1229-38.
11- Marinangeli F, Ciccozzi A, Leonardis M, Aloisio L, Mazzei A, Paladini A, Porzio G, Marchetti P, Varrassi G.Use of strong opioids in advanced cancer pain: a ran-domized trial. J Pain Symptom Manage 2004; 27(5):409-16.12. Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Ficorella C, Verna L, Tirelli W,Villari P, Arcuri E.Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage 2006;31(3):242-47.
13. Ripamonti C, Bandieri E.Pain therapy. Crit Rev Oncol Hematol 2009;70(2):145-59..
14. Messina J, Darwish M, Fine PG.Fentanyl buccal tablet. Drugs Today (Barc) 2008;44(1):41-54.
15. Mercadante S, Bruera E. Opioid switching: a systemat-ic and critical review. Cancer Treat Rev 2006; 32: 304-315.16. Harris JT, Suresh Kumar K, Rajagopal MR. Intrave-nous morphine for rapid control of severe cancer pain. Palliat Med 2003; 17: 248-56.17. Miaskowski C, Dodd MJ, West C, Paul SM, Tripathy D, Koo P, Schumacher K. Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 2001; 19(23):4275-79.

Thank you for copying data from http://www.arastirmax.com